Latest Articles
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - BIOENGINEER.ORG
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment BIOENGINEER.ORG
Published: Jan. 19, 2026, 3:06 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - Bioengineer.org
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment Bioengineer.org
Published: Jan. 19, 2026, 3:06 p.m.
Link copied to clipboard!